Balance Sheet Charles River Laboratories International, Inc.
Stocks
CRL
US1598641074
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 226.58 USD | -1.18% |
|
+0.99% | +13.59% |
| 07-20 | Analyst recommendations: Global Payments, Charles Schwab, US Bancorp, Datadog, Netflix… | |
| 07-13 | BofA Adjusts Price Target on Charles River Laboratories International to $264 From $220 | MT |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Cash And Equivalents | 241M | 234M | 277M | 195M | 214M | |||||
Short Term Investments | 1.06M | - | - | - | - | |||||
Total Cash And Short Term Investments | 242M | 234M | 277M | 195M | 214M | |||||
Accounts Receivable, Total | 643M | 752M | 780M | 721M | 709M | |||||
Total Receivables | 643M | 752M | 780M | 721M | 709M | |||||
Inventory | 199M | 256M | 380M | 279M | 299M | |||||
Prepaid Expenses | 93.54M | 89.34M | 87.88M | 103M | 96.11M | |||||
Restricted Cash | 4.02M | 6.19M | 5.8M | 9.54M | 666K | |||||
Other Current Assets, Total | 92.22M | 101M | 77.58M | 96.26M | 129M | |||||
Total Current Assets | 1.27B | 1.44B | 1.61B | 1.4B | 1.45B | |||||
Gross Property Plant And Equipment | 2.69B | 3.02B | 3.37B | 3.47B | 3.55B | |||||
Accumulated Depreciation | -1.1B | -1.16B | -1.34B | -1.45B | -1.54B | |||||
Net Property Plant And Equipment | 1.58B | 1.86B | 2.03B | 2.02B | 2.02B | |||||
Long-term Investments | 201M | 312M | 244M | 218M | 207M | |||||
Goodwill | 2.71B | 2.85B | 3.1B | 2.85B | 2.76B | |||||
Other Intangibles, Total | 1.06B | 955M | 864M | 723M | 340M | |||||
Deferred Tax Assets Long-Term | 40.23M | 41.26M | 40.28M | 42.18M | 67.33M | |||||
Other Long-Term Assets, Total | 152M | 148M | 309M | 278M | 293M | |||||
Total Assets | 7.02B | 7.6B | 8.2B | 7.53B | 7.14B | |||||
Liabilities | ||||||||||
Accounts Payable, Total | 198M | 206M | 169M | 140M | 149M | |||||
Accrued Expenses, Total | 475M | 417M | 441M | 386M | 509M | |||||
Current Portion of Long-Term Debt | 101K | 1.35M | 3.17M | 155K | 166K | |||||
Current Portion of Leases | 35.96M | 48.86M | 57.31M | 56.93M | 60.89M | |||||
Current Income Taxes Payable | 26.16M | 39.9M | 38.8M | 31.9M | 39M | |||||
Unearned Revenue Current, Total | 279M | 356M | 327M | 338M | 317M | |||||
Other Current Liabilities | 18.7M | 22.83M | 18.38M | 40.58M | 45.5M | |||||
Total Current Liabilities | 1.03B | 1.09B | 1.06B | 994M | 1.12B | |||||
Long-Term Debt | 2.64B | 2.68B | 2.62B | 2.21B | 2.11B | |||||
Long-Term Leases | 278M | 418M | 445M | 509M | 459M | |||||
Unearned Revenue Non Current | 20.58M | 25.8M | 30.92M | 34.29M | 45.63M | |||||
Pension & Other Post Retirement Benefits | 105M | - | - | - | - | |||||
Deferred Tax Liability Non Current | 240M | 216M | 191M | 107M | 95.2M | |||||
Other Non Current Liabilities | 117M | 149M | 192M | 161M | 92.67M | |||||
Total Liabilities | 4.43B | 4.58B | 4.54B | 4.02B | 3.92B | |||||
Common Stock, Total | 505K | 509K | 513K | 511K | 492K | |||||
Additional Paid In Capital | 1.72B | 1.8B | 1.91B | 1.97B | 1.95B | |||||
Retained Earnings | 981M | 1.43B | 1.89B | 1.81B | 1.39B | |||||
Treasury Stock | - | - | - | - | - | |||||
Comprehensive Income and Other | -165M | -262M | -196M | -317M | -172M | |||||
Total Common Equity | 2.53B | 2.98B | 3.6B | 3.46B | 3.16B | |||||
Minority Interest | 57.17M | 47.21M | 62.12M | 46.58M | 46.56M | |||||
Total Equity | 2.59B | 3.02B | 3.66B | 3.51B | 3.21B | |||||
Total Liabilities And Equity | 7.02B | 7.6B | 8.2B | 7.53B | 7.14B | |||||
Supplemental Items | ||||||||||
ECS Total Shares Outstanding on Filing Date | 50.49M | 50.99M | 51.35M | 51.14M | 49.23M | |||||
ECS Total Common Shares Outstanding | 50.48M | 50.94M | 51.34M | 51.14M | 49.22M | |||||
Book Value / Share | 50.21 | 58.42 | 70.06 | 67.69 | 64.3 | |||||
Tangible Book Value | -1.24B | -829M | -362M | -109M | 60.38M | |||||
Tangible Book Value Per Share | -24.53 | -16.27 | -7.06 | -2.12 | 1.23 | |||||
Total Debt | 2.95B | 3.15B | 3.13B | 2.78B | 2.63B | |||||
Net Debt | 2.71B | 2.91B | 2.85B | 2.59B | 2.42B | |||||
Debt Equivalent of Unfunded Proj. Benefit Obligation | 36.97M | 13.01M | 21.22M | 33.31M | 32.17M | |||||
Debt Equivalent Oper. Leases | 406M | 597M | 712M | 816M | 876M | |||||
Minority Interest, Total (Incl. Fin. Div) | 57.17M | 47.21M | 62.12M | 46.58M | 46.56M | |||||
Equity Method Investments, Total | 150M | 312M | 244M | 218M | 207M | |||||
Account Code - Inventory Valuation | 6 | 6 | 6 | 6 | 5 | |||||
Inventories - Raw Materials, Total | 33.12M | 38.89M | 42.3M | 43.04M | 40.96M | |||||
Inventories - Work In Process, Total | 40.27M | 48.37M | 59.73M | 51.78M | 88.74M | |||||
Inventories - Finished Goods, Total | 126M | 169M | 278M | 184M | 169M | |||||
Land - (BS) | 59.49M | 58.19M | 79.55M | 71.74M | 72.02M | |||||
Buildings, Total | 988M | 964M | 1.05B | 1.07B | 1.1B | |||||
Machinery, Total | 1B | 1.11B | 1.28B | 1.33B | 1.41B | |||||
Full Time Employees | 18.6K | 20K | 20.4K | 18.7K | 18.3K | |||||
Part Time Employees | 1.4K | 1.4K | 1.4K | 1.4K | 1.4K | |||||
Accumulated Allowance for Doubtful Accounts (Supple) | 7.18M | 11.28M | 25.72M | 18.3M | 10.46M | |||||
Order Backlog | 2.8B | 3.5B | 3.13B | 2.79B | 2.66B |
Select your edition
All financial news and data tailored to specific country editions
















